These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 3072902)
1. Mechanisms by which genes encoding growth factors and growth factor receptors contribute to malignant transformation. Kraus MH; Pierce JH; Fleming TP; Robbins KC; Di Fiore PP; Aaronson SA Ann N Y Acad Sci; 1988; 551():320-35; discussion 336. PubMed ID: 3072902 [No Abstract] [Full Text] [Related]
2. Involvement of oncogene-coded growth factors in the neoplastic process. Robbins KC; King CR; Giese NA; Leal F; Igarashi H; Aaronson SA Gene Amplif Anal; 1986; 4():161-76. PubMed ID: 2851529 [No Abstract] [Full Text] [Related]
3. Control of human breast cancer by estrogen, growth factors, and oncogenes. Dickson RB; Lippman ME Cancer Treat Res; 1988; 40():119-65. PubMed ID: 2908648 [No Abstract] [Full Text] [Related]
4. Mechanisms by which EGF receptor and TGF alpha contribute to malignant transformation. Di Marco E; Pierce JH; Aaronson SA; Di Fiore PP Nat Immun Cell Growth Regul; 1990; 9(3):209-21. PubMed ID: 2196461 [TBL] [Abstract][Full Text] [Related]
5. Growth factors and oncogenes in human malignant glioma. Westermark B; Nister M; Heldin CH Neurol Clin; 1985 Nov; 3(4):785-99. PubMed ID: 3001490 [TBL] [Abstract][Full Text] [Related]
6. Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis. Cao Y Cell Cycle; 2005 Feb; 4(2):228-30. PubMed ID: 15655347 [TBL] [Abstract][Full Text] [Related]
7. Peptide regulatory factors and malignancy. Steel CM Lancet; 1989 Jul; 2(8653):30-4. PubMed ID: 2567802 [No Abstract] [Full Text] [Related]
8. Growth factors in cancer and their relationship to oncogenes. Salomon DS; Perroteau I Cancer Invest; 1986; 4(1):43-60. PubMed ID: 3006881 [No Abstract] [Full Text] [Related]
9. The growth factor-platelet-transformation connection. Bowen-Pope DF Dev Biol (N Y 1985); 1986; 3():111-28. PubMed ID: 3077960 [No Abstract] [Full Text] [Related]
10. Different mechanisms are responsible for oncogene activation in human mammary neoplasia. Kraus MH; Di Fiore PP; Pierce JH; Aaronson SA Cancer Treat Res; 1988; 40():49-66. PubMed ID: 2908661 [No Abstract] [Full Text] [Related]
11. Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. Riedel H; Massoglia S; Schlessinger J; Ullrich A Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1477-81. PubMed ID: 3257824 [TBL] [Abstract][Full Text] [Related]
12. [The role of growth factors and platelet-aggregating substances in the development of neoplasm metastases]. Farbiszewski R Postepy Hig Med Dosw; 1989; 43(5-6):453-73. PubMed ID: 2488246 [TBL] [Abstract][Full Text] [Related]
13. Concomitant synthesis of growth factors and their receptors--an aspect of malignant transformation. Alexander P; Currie G Biochem Pharmacol; 1984 Mar; 33(6):941-3. PubMed ID: 6324807 [TBL] [Abstract][Full Text] [Related]
14. The molecular action of platelet-derived growth factor. Cochran BH Adv Cancer Res; 1985; 45():183-216. PubMed ID: 3004121 [No Abstract] [Full Text] [Related]
18. Production of insulin-like growth factors, platelet-derived growth factor, and transforming growth factors and their role in the density-dependent growth regulation of a differentiated embryonal carcinoma cell line. van Zoelen EJ; Koornneef I; Holthuis JC; Ward-van Oostwaard TM; Feijen A; de Poorter TL; Mummery CL; van Buul-Offers SC Endocrinology; 1989 Apr; 124(4):2029-41. PubMed ID: 2538320 [TBL] [Abstract][Full Text] [Related]